MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$66,216K
(42.61%↑ Y/Y)
Unrealized gain (loss) on
marketable securities and...
$202K
(11.60%↑ Y/Y)
Net loss
-$66,418K
(42.52%↑ Y/Y)
Interest income
$15,747K
(4.88%↑ Y/Y)
Loss before income
taxes
-$64,359K
(44.30%↑ Y/Y)
Provision for income taxes
$2,059K
Total other income,
net
$6,610K
(31.80%↑ Y/Y)
Product
$451,360K
(150.67%↑ Y/Y)
Interest expense
$8,935K
(13.84%↑ Y/Y)
Other income
(expense), net
-$202K
(-134.47%↓ Y/Y)
Loss from operations
before other income...
-$70,969K
(41.14%↑ Y/Y)
Total revenues
$451,360K
(150.67%↑ Y/Y)
Total operating
expenses
$522,329K
(72.09%↑ Y/Y)
Selling, general and
administrative
$427,323K
(80.07%↑ Y/Y)
Research and development
$64,322K
(20.48%↑ Y/Y)
Cost of
sales-Product
$30,684K
Back
Back
Income Statement
source: myfinsight.com
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)